BIOANALYTICAL SYS INC's ticker is BASI and the CUSIP is 09058M103. A total of 11 filers reported holding BIOANALYTICAL SYS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $17,000 | +183.3% | 3,447 | +85.8% | 0.00% | – |
| Q3 2019 | $6,000 | +200.0% | 1,855 | +85.5% | 0.00% | – |
| Q2 2019 | $2,000 | -33.3% | 1,000 | -44.4% | 0.00% | – |
| Q1 2019 | $3,000 | -97.4% | 1,800 | -97.5% | 0.00% | – |
| Q3 2018 | $114,000 | -20.8% | 71,368 | -18.7% | 0.00% | – |
| Q2 2018 | $144,000 | +45.5% | 87,800 | +41.4% | 0.00% | – |
| Q1 2018 | $99,000 | -31.7% | 62,094 | +4.5% | 0.00% | – |
| Q4 2017 | $145,000 | +314.3% | 59,400 | +194.1% | 0.00% | – |
| Q3 2017 | $35,000 | – | 20,200 | +11122.2% | 0.00% | – |
| Q4 2014 | $0 | – | 180 | +17900.0% | 0.00% | – |
| Q3 2013 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 110,000 | $270,000 | 0.02% |
| Versant Capital Management, Inc | 19,191 | $47,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 178,510 | $441,000 | 0.01% |
| Virtu Financial LLC | 32,214 | $79,000 | 0.00% |
| NORTH STAR ASSET MANAGEMENT INC | 15,000 | $37,000 | 0.00% |
| Renaissance Technologies | 244,200 | $598,000 | 0.00% |
| UBS Group AG | 394 | $1,000 | 0.00% |
| Advisor Group, Inc. | 100 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 52 | $0 | 0.00% |
| STATE STREET CORP | 10,200 | $25,000 | 0.00% |